InvestorsHub Logo
Followers 37
Posts 7026
Boards Moderated 1
Alias Born 09/06/2014

Re: guardiangel post# 25543

Thursday, 10/09/2014 8:32:52 AM

Thursday, October 09, 2014 8:32:52 AM

Post# of 30046
Someone needs to do some deductive reasoning.

"For what it's worth..William is rolling out the Lung Cancer Test in Mid October as he stated..." proves that GCDX is not involved with Radient.

"ProvistaDx has always had Free Access to DR-70..Off and on patent..Of course Mac allowed them to do it.." proves that Provista has no need to takec over or merge with Radient - they already have DR-70 if they want it.

"DR-70 being a big part of their Breast Cancer Test..." is a fabrication. This is simply not true. Provista's test is for proetion markers that are specific to breast cancer. Adding DR-70 would eliminate this advantage.

But even if it were true, since we agree that Provista has free access to DR-70, it still does not mean Provista will take over or merge with Radient. They already have DR-70 for free if they want it.

Which they do not. Provista is not merging with or taking over Radient. That rumor is just wishful thinking -- Better odds wishing for a lottery win.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.